TrialAllergy2018
A randomized, double-blind, placebo-controlled, dose-finding trial with Lolium perenne peptide immunotherapy.
R Mösges et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papertrialcites it
TrialAllergy2018
R Mösges et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.